Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP policies and guidelines news

Show

From To
The Irish Times view on PrEP and HIV: A matter of urgency

There should be no delay in proceeding with this vital preventive health initiative.

Published
29 April 2019
From
Irish Times
How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

"Nothing for us without us!" When PrEP4All co-founders James Krellenstein and Nick Faust shouted these words at Centers for Disease Control and Prevention (CDC) Director Robert Redfield, M.D., at AIDSWatch in Washington, D.C., on April 1, it was like they planned it all along.

Published
25 April 2019
From
The Body
US: The Justice Department Is Looking Into Gilead’s PrEP Profits

The Justice Department will investigate whether drug manufacturer Gilead violated the terms of the federal government’s patent on Truvada as pre-exposure prophylaxis, according to the Washington Post.

Published
25 April 2019
From
Out
Ireland: Taoiseach and Minister for Health confirm introduction of PrEP programme in 2019

Taoiseach Leo Varadkar welcomed the publication of a draft report by the Health Information and Quality Authority (HIQA) on the introduction of a pre-exposure prophylaxis (PrEP) programme aimed at preventing HIV. Health Minister Simon Harris encouraged interested parties and members of the public to give their feedback on the draft report during the consultation process which runs to 28th of May, The public consultation is at HIQA’s website: https://www.hiqa.ie/reports-and-publications/consultation/draft-hta-prep-programme

Published
23 April 2019
From
Irish Ministry of Health
Hivpoint Helsinki welcomes Pre-Exposure Prophylaxis – Finnish national guidelines are here, and generic medicines hit the market soon

The National Institute for Health and Welfare recommends PrEP for people with a high risk for HIV transmission. As a part of a comprehensive prevention program, PrEP has reduced new HIV transmissions in all countries where it is available. When used correctly, PrEP provides up to 99% reduction in HIV risk. The Finnish national guidelines are released today, 17 April 2019.

Published
17 April 2019
From
Hivpoint
Letter to FDA Regarding Application for Descovy as Pre-Exposure Prophylaxis for HIV

TAG and PrEP4All sent this letter to Dr. Debra Birnkrant of the FDA, outlining and expressing our serious concerns about Gilead’s supplemental New Drug Application for Descovy (FTC/TAF) as HIV-1 preexposure prophylaxis (PrEP). There are several specific recommendations in the letter for this approval process, including recomending that the FDA convene a public meeting of the Antiviral Drug Advisory Committee.

Published
17 April 2019
From
Treatment Action Group
London councils agree to take 60% new PrEP trial patients, but it might not be enough

A stalemate over who would take more patients on to PrEP trial has ended. London councils have agreed to increase places on city PrEP trial.

Published
15 April 2019
From
Gay Star News
London: Tower Hamlets Mayor calls for Government to fund PrEP for all to stop HIV transmission

John Biggs, Mayor of Tower Hamlets has written to Matt Hancock the Secretary of State for health, to call for the funding of HIV treatment that could stop the spread of HIV, saving the NHS millions of pounds.

Published
11 April 2019
From
Tower Hamlets council
PrEP: Camden councillor Jonathan Simpson urges NHS to extend availability of preventative HIV drug

A Camden councillor urged the government to make the preventative HIV drug PrEP more available, during a passionate speech at a council meeting last night.

Published
10 April 2019
From
Ham & High
Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

For years, the U.S. HIV prevention community has known that pre-exposure prophylaxis (PrEP) is prohibitively expensive for many patients who need it. Now, new research presented at the 2019 National HIV Prevention Conference (NHPC) in Atlanta finds that not only is PrEP expensive for individual patients, it's also not cost-effective for the health system as a whole.

Published
09 April 2019
From
The Body

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.